D5BH:F:F-Xtrackers - MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 83.4

Change

-1.03 (-1.22)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.74 (-1.42%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

-13.56 (-2.41%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.79 (-1.38%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.47%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

-1.29 (-1.30%)

USD 51.63B
0ZC:F Zscaler Inc

-3.30 (-1.48%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.39%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.66 (-1.29%)

USD 24.77B

ETFs Containing D5BH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.02% 62% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.02% 62% D 57% F
Trailing 12 Months  
Capital Gain 16.82% 87% B+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.82% 85% B 68% D+
Trailing 5 Years  
Capital Gain 96.47% 87% B+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 96.47% 87% B+ 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 13.34% 83% B 73% C
Dividend Return 13.34% 81% B- 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.27% 36% F 79% B-
Risk Adjusted Return 87.36% 84% B 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.